Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy
H Hirano, K Kato - Japanese journal of clinical oncology, 2019 - academic.oup.com
Systemic treatment of advanced esophageal squamous cell carcinoma (ESCC) mainly
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …
[PDF][PDF] Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy
H Hirano, K Kato - Japanese Journal of Clinical Oncology, 2019 - researchgate.net
Systemic treatment of advanced esophageal squamous cell carcinoma (ESCC) mainly
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …
Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy.
H Hirano, K Kato - Japanese Journal of Clinical Oncology, 2019 - europepmc.org
Systemic treatment of advanced esophageal squamous cell carcinoma (ESCC) mainly
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …
Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy
H Hirano, K Kato - Japanese Journal of Clinical Oncology, 2019 - academic.oup.com
Systemic treatment of advanced esophageal squamous cell carcinoma (ESCC) mainly
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …
[引用][C] Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy
H Hirano, K Kato - Japanese Journal of Clinical Oncology, 2019 - cir.nii.ac.jp
Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy,
molecular-targeting therapy and immunotherapy | CiNii Research CiNii 国立情報学研究所 学術 …
molecular-targeting therapy and immunotherapy | CiNii Research CiNii 国立情報学研究所 学術 …
Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy
H Hirano, K Kato - Japanese journal of clinical oncology, 2019 - pubmed.ncbi.nlm.nih.gov
Systemic treatment of advanced esophageal squamous cell carcinoma (ESCC) mainly
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …
Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy.
H Hirano, K Kato - Japanese Journal of Clinical Oncology, 2019 - search.ebscohost.com
Systemic treatment of advanced esophageal squamous cell carcinoma (ESCC) mainly
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …
consists of cytotoxic agents, aiming to palliate symptoms and prolong survival. Cisplatin and …